A 53-year-old 
Introduction

Acute erythroid leukemias are characterized by a predominant erythroid population and account for approximately 2-5% of all cases of acute leukemia. Most authors agree that two main subtypes exist: the M6 acute leukemia according to the French-America-British (FAB) criteria, in which mixed granulocytic and erythroblastic cellular components are present; and a pure erythroid acute proliferation not taken into consideration in the FAB classification (1-4). The World Health Organization (WHO) classification of pure erythroid leukemia is >80% of marrow cells showing no evidence of any significant myeloblastic component (< 3%) and usually <10% mature erythroids (5).
Hemophagocytic syndrome (HPS) is a reactive disorder of the mononuclear phagocytic system, characterized by benign, generalized histiocytic proliferation with marked hemophagocytosis in the bone marrow (6, 7 
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(94.8%) and multiple sites of active hemophagocytosis (Fig. 1 
Discussion
Leukemia purely comprising erythrocytic precursors was first described by Di Guglielmo in 1928 (10) (8) . Leukemia-associated HPS is relatively rare. In fact, to the best of our knowledge, few reports have described AML associated with HPS (11, 12) , and only one report has examined acute erythroid leukemia (13) . The present de- 
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